Kilitch Drugs (India) Limited
Incorporated in 1978, Kilitch Drugs Ltd is engaged in the operation and management of Pharmaceutical Products
What Kilitch files
- Others45
- Important14
- Board Meeting9
- Dividend/Bonus4
- Updates3
- QIP/Rights/Pref.2
Kilitch Drugs has shared its FY25-26 Annual Report web-link with relevant shareholders and announced its 34th AGM via VC. Investors are urged to update KYC details and dematerialize physical securities, crucial for continued electronic payments and compliance.
Kilitch Drugs (India) Ltd. will hold its 34th Annual General Meeting via Video Conferencing to transact company business. The company has announced a book closure period to determine eligible members for sending notice and exercising voting rights.
Kilitch Drugs (India) initiated operations at its new Nutraceutical Manufacturing Block in Maldev, Raigad, Maharashtra. This strategic operational expansion enhances the company's manufacturing capabilities in the growing nutraceutical segment.
Kilitch Drugs issued letters to shareholders without registered emails, providing web links to its FY25 Annual Report and 33rd Annual General Meeting (AGM) notice. The AGM will be held virtually. Investors are also reminded to update KYC details and dematerialize physical shares.
Kilitch Drugs (India) will hold its 33rd Annual General Meeting via video conference on September 26. The company's share transfer books will be closed from September 19 to September 26. E-voting facilities will be available for shareholders.